
zzso that are selectively or abundantly expressed in cancer cells have been used for clinical trials, mostly in patients with advanced disease, and appear to be better vaccines than whole zzso zzso vaccines have emerged from different categories of cancer zzso Strategies involving various forms of peptides have been used either alone or combined with different zzso zzso or zzso cells to enhance specific immune zzso Although individual patients have zzso no strategy has emerged as universally zzso neither has any route of zzso Increasingly sensitive methods have correlated clinical responses with measurable immune responses to vaccination in some zzso 

